Citation:
Gamble J-M, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR. Scientific Reports. Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85054774677&partnerID=MN8TOARS